|
C16ORF57 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.350900E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.996900E-04 |
| Normal-vs-Stage2 |
4.30020000000697E-05 |
| Normal-vs-Stage3 |
1.122660E-03 |
| Normal-vs-Stage4 |
2.085600E-01 |
| Stage1-vs-Stage2 |
1.888230E-01 |
| Stage1-vs-Stage3 |
6.266600E-01 |
| Stage1-vs-Stage4 |
6.457600E-02 |
| Stage2-vs-Stage3 |
1.142960E-01 |
| Stage2-vs-Stage4 |
1.339640E-02 |
| Stage3-vs-Stage4 |
1.348390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.430400E-04 |
| Normal-vs-AfricanAmerican |
5.701800E-03 |
| Normal-vs-Asian |
7.938000E-01 |
| Caucasian-vs-AfricanAmerican |
7.765800E-01 |
| Caucasian-vs-Asian |
2.307800E-01 |
| AfricanAmerican-vs-Asian |
2.749400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.66400000000322E-05 |
| Normal-vs-Female |
1.021670E-03 |
| Male-vs-Female |
3.466800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.192200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.276710E-03 |
| Normal-vs-Age(61-80Yrs) |
2.04569999999737E-05 |
| Normal-vs-Age(81-100Yrs) |
2.509700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.961500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.711670E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.102960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.919000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.378600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.806600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.427020E-01 |
| Normal-vs-Grade 2 |
5.86120000000134E-05 |
| Normal-vs-Grade 3 |
7.87990000000738E-05 |
| Normal-vs-Grade 4 |
5.678000E-01 |
| Grade 1-vs-Grade 2 |
5.117400E-01 |
| Grade 1-vs-Grade 3 |
7.407200E-01 |
| Grade 1-vs-Grade 4 |
1.579650E-01 |
| Grade 2-vs-Grade 3 |
4.906200E-01 |
| Grade 2-vs-Grade 4 |
3.080400E-03 |
| Grade 3-vs-Grade 4 |
1.061590E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.46279999954946E-07 |
| Normal-vs-ccB subtype |
6.794400E-02 |
| ccA subtype-vs-ccB subtype |
1.96040000011166E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.159100E-04 |
| Normal-vs-N1 |
4.458400E-01 |
| N0-vs-N1 |
7.199600E-02 |
|
|
